Stock Warrant
WARRANTVeraxa Biotech AG Warrants
No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.
VRXAW is Veraxa Biotech AG — a non-dividend-paying stock. Trading at $0.10.
Stock snapshot
| Price | $0.10 |
| Market cap | — |
| Sector | — |
| Exchange | NCM |
| Pays dividend | No |
About VRXAW
Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.
Frequently asked
What is VRXAW's current stock price?
VRXAW (Veraxa Biotech AG) is currently trading at $0.10.
Does VRXAW pay a dividend?
VRXAW (Veraxa Biotech AG) does not currently pay a regular dividend.
Track VRXAW in DiviDrip
Add VRXAW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VRXAW and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.